Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Early onset and pustules indicate severe hair follicle inflammation, and while antibiotics help, the condition often worsens after treatment stops.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Some medications can cause acne, and stopping these drugs is the main treatment.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Nano-sized plant-based chemicals could improve cervical cancer treatment by being more effective and causing fewer side effects than current methods.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

It's unclear which molecules best characterize dry skin due to inconsistent findings.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Trichoscopy is a useful tool for diagnosing hair and scalp issues, but doctors must be careful to avoid mistakes.

Natural products can help overcome cancer drug resistance.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

M. restricta may cause Malassezia folliculitis, especially in teens and twenties.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

CNGA3, GLUD1, and SIRT1 are promising targets for treating aging and glioblastoma.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Keratoacanthoma comes from hair follicle cells.

Dermocosmetics help manage skin issues in cancer patients, improving outcomes and reducing treatment interruptions.